Acer therapeutics and relief therapeutics announce presentation of four acer-001 posters at the upcoming simd and gmdi conferences

Data to be presented suggests acer-001 could represent a potential alternative to sodium and glycerol phenylbutyrate for treatment of ucds data to be presented suggests acer-001 could represent a potential alternative to sodium and glycerol phenylbutyrate for treatment of ucds

ACER Ratings Summary

ACER Quant Ranking